FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

New help for people just diagnosed with MS










































NEW HELP and advice aims to tackle the lack of support that people newly diagnosed with MS are given from their GPs.
Read more »

 

Explaining Executive Deficits in Multiple Sclerosis Patients




















Research supports the slowed processing speed in the executive deficits found in individuals with multiple sclerosis (MS), according to a paper from the Kessler Foundation.
Read more »

 

Oklahoma Medical Research Foundation selected to receive Innovation Grant from EMD Serono













An Oklahoma Medical Research Foundation scientist has been selected to receive one of only five Grants for Multiple Sclerosis Innovation awarded this year by the pharmaceutical company EMD Serono.
Read more »

 

Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients























The authors investigated the host response induced by selected antigenic peptides, to gain a better understanding of the role of these two pathogens. The data demonstrated that both Epstein–Barr virus (EBV), and Mycobacterium avium subsp. paratuberculosis (MAP) epitopes elicit a consistent humoral response in MS patients compared to HCs, and that the aforementioned peptides are able to induce a T–cell–mediated response that is MS correlated.

Story Source: The above story is based on materials provided by MDLINX
Note: Materials may be edited for content and length

 

Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics: STUDY

Wednesday

 

Chemical Compound Decreases Effects of Multiple Sclerosis




























Given the debilitating effects of Multiple sclerosis (MS), an aggressive search is on among scientists to find a cure. Currently available therapies are only partially effective, however, in preventing the onset of permanent disability in MS patients. What would be immensely helpful is a drug that could minimize the degeneration of axons, thus reducing the rate and degree of MS progression. Better still would be if this drug could stimulate “remyelination,” the re-sheathing of the axons, restoring fast and uninterrupted flow of nerve impulses.
Read more »

 

Yeovil man overcomes illness to complete gruelling charity trek across Morocco






























A Yeovil man overcame a crippling stomach bug to complete a gruelling charity trek across Morocco earlier this month.
Read more »

Labels:


 

Multiple Sclerosis: Can lifestyle affect depression risk?

















































Dr James O’Malley


New research published today in BMC Psychiatry has suggested lifestyle factors can play a role in depression risk for people with MS. In this guest post Dr James O’Malley, Research Communications Officer at the MS Society (UK) tells us more about MS and its association with depression.
Read more »

Labels:


 

My Multiple Sclerosis ‘Elf on the Shelf’

























Trevis Gleason

Ah, it’s the time of year when we spend too much money on gifts people don’t need, too much time worrying about perfection, and too much effort just getting out of bed. It’s also a time for the warmth and glow of friends and family, a time of simplicity and grace.

It’s the holiday season.
Read more »

 

Information processing speed impairment and cerebellar dysfunction in relapsing–remitting multiple sclerosis: STUDY

Tuesday

 

Investigating stem cells as a multiple sclerosis stem cell treatment option





























ThriveMD has extensive experience in performing stem cell therapy for a variety of joint and spine pain conditions. Autologous (your own) adipose (fat) and bone marrow stem cells have the potential to regenerate damaged tissue and reduce pain. In addition to the treatment of numerous orthopedic conditions, ThriveMD also offers treatment of systemic and autoimmune diseases including MS and COPD.
Read more »

Labels:


 

Servier and GeNeuro to develop multiple sclerosis therapy































Servier has announced a new collaboration with GeNeuro on the development of a potentially groundbreaking therapy for multiple sclerosis (MS).
Read more »

 

Bishop awarded grant to research MS patients’ health care needs































Malachy Bishop


UK professor has goal of providing better health care for MS patients
Read more »

 

Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis: STUDY

 

T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases: STUDY

Monday

 

MS Research Highlights In 2014 That Offer New Leads In Stopping MS, Restoring Function Lost, And Ending MS Forever

























NEW YORK, Dec. 4, 2014 /PRNewswire-USNewswire/ -- Significant research progress occurred in 2014, offering new leads that are driving efforts to stop MS, restore function lost, and end MS forever.   In 2014, the National Multiple Sclerosis Society invested $50.6 million in 380 new and ongoing research projects and initiatives. Here is a brief summary of the research highlights reflecting the Society's commitment to pursue promising opportunities wherever they exist, while focusing on three priority areas: progressive MS, nervous system repair, and wellness/lifestyle, which have been singled out under each research goal below when applicable.
Read more »

 

GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of Multiple Sclerosis


































Release date- 02122014 - Geneva, Switzerland, and Suresnes, France- GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has entered into a strategic partnership with Servier, the leading independent French pharmaceutical company, to develop and market GNbAC1 in Multiple Sclerosis (MS).
Read more »

 

Diagnosed with Multiple Sclerosis













The moment the doctor said “there is an abnormality on the MRI” my world stopped for a split second. He started to turn around and was pointing to the back of his neck. I stopped him and said “wait, did you say abnormality?” The next words out of his mouth were “there is a demyelination on the c spine, which is indicative of MS but not conclusive.” My next words were strong and harsh. It’s indicative but not conclusive? So why would you say that to me? Why would you put that worry in my head if it’s not a firm diagnosis? What are our next steps?
Read more »

 

A low-cost cognitive rehabilitation with a commercial video game improves sustained attention and executive functions in multiple sclerosis: a pilot study : STUDY









































The study aims to evaluate the effectiveness of a home–based cognitive rehabilitation (CR) program based on the video game Dr Kawashima’s Brain Training (DKBT; Nintendo, Japan), in improving attention, processing speed, and working memory of patients with multiple sclerosis (MS). The authors suggest that a home–based DKBT program may improve cognitive functions, some aspects of QoL, and cognitive fatigue in patients with MS
Click here to read original article

Labels: ,


 

Improving physical functional and quality of life in older adults with multiple sclerosis via a DVD-delivered exercise intervention: a study protocol: STUDY

Sunday

 

Foot Care: Put Some Spring in Your Step






























Your feet, your foundation


Your feet are, quite literally, your foundation. They are active and complex networks of bones, joints, tissues, muscles, and nerve endings that all work together to help coordinate motion in the rest of your body.
Read more »

Labels:


 

Multiple Sclerosis Breakthrough? Human Cells Injected Into Mice Created Smarter Mice, Scientist Says
















































Scientists have figured out how to put human neurons (the "thinking" cells) into mice brains. Does that mean Fievel Mousekewitz from An American Tale met Dr. Frankenstein?
Read more »

 

Vitamin D, What can it do for you?































Vitamin D has been a major topic of discussion recently. Over the past 5 years this vitamin has been the focus of many scientific communities. While some of the areas of impact need more research, there is quite a bit of promise from repeated data, which makes the case for increasing daily Vitamin D intake.
Read more »

Labels:


 

Multiple sclerosis, researchers find link to other diseases





























A rogue protein may lie at the bottom of multiple sclerosis.
Read more »

 

Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls: STUDY

Saturday

 

Public Intoxication? Visiting vet says APD mistook his MS for drunkenness























Don and Jackie Timmerman


 On Nov. 7, at approximately 10:45pm, Austin Police Department Officer Jason Jones arrested a husband and wife for public intoxication, after they had walked into the APD's temporary detention facility on Neches Street Downtown, asking for the whereabouts of their rental car. The couple, Don and Jackie Timmerman, were visiting from New Jersey, here to watch that weekend's UT Longhorn football game against West Virginia and take part in Veterans Recognition Day. Don's a retired lieutenant colonel, with 28 years in the Army.
Read more »

 

New Spinal Injury Drug Helps Regeneration of Nerve Cells: Paralyzed Lab Rats Showed Improvement






























An experimental compound that can help regenerate nerve cells shows promise in animal tests and this could pave way for a new therapy that can restore movements in individuals paralyzed because of spinal cord injuries.
Read more »

 

Urinary Incontinence - Symptom Evaluation



















Urinary Incontinence can be temporary or persistent. It is common with aging due to weak bladder muscles. Women are more commonly affected compared to men, and this can be attributed to hormonal changes, pregnancy, childbirth, and anatomy of the urogenital tract (higher incidence of infections), among others. Obesity is another factor that increases the risk of urinary incontinence.
Read more »

Labels:


 

First MS patients treated with Genzyme’s Lemtrada in US
















































Genzyme has announced that the first patient with relapsing forms of multiple sclerosis (MS) has been treated with Lemtrada (alemtuzumab).
Read more »

Labels:


 

The Cognitive Health Questionnaire: Initial Psychometric Data in a Multisite Multiple Sclerosis Sample: STUDY

Friday

 

9 Ways to Deal With MS Burnout





















Coping with a disease such as multiple sclerosis is not easy. The everyday physical and emotional demands of – reining-in MS symptoms such as fatigue, visiting doctors and other healthcare professionals for therapy, tests, and treatments, while attempting to do the everyday activities of work and family, can leave patients feeling fatigued, beaten, and burned out.
Read more »

 

Swann urges community to make ‘Save the Dal’ resolution


























Mr Robin Swann MLA, the North Antrim Ulster Unionist Westminster candidate and Chairman of the Stormont Employment and Learning Committee, has called on entire community to make it one of their New Year resolutions to “save the Dalriada Hospital in Ballycastle by ensuring the Northern Health Trust, and especially the DUP Health Minister, permanently reverse the decision to close the multiple sclerosis centre”.
Read more »

 

New help for people just diagnosed with MS






































Professor Neil Scolding - Neurology


NEW HELP and advice aims to tackle the lack of support that people newly diagnosed with MS are given from their GPs.
Read more »

 

Lichfield musicians' Christmas single will help make a difference

Genevieve Corbett, vocalist on charity single Christmas You Christmas Me, with Iain Kerr and Stuart Turner of Swan Music.


TWO LICHFIELD musicians have joined forces to produce a Christmas single aimed at raising £20,000 for charity.
Read more »

 

Multiple sclerosis and seizures: incidence and prevalence over 40 years: STUDY

Thursday

 

Avril Lavigne Launches Foundation to Support Children and Youth with Disabilities and Serious Illnesses
































The Avril Lavigne Foundation will partner with Easter Seals to fund programs for kids with disabilities and their families
Read more »

 

BUSM researcher receives prestigious Massachusetts Neuroscience Consortium award





























Carmela Abraham, PhD, professor of biochemistry and pharmacology at Boston University School of Medicine, was one of six recipients of this year's Massachusetts Neuroscience Consortium Award out of nearly 60 applicants. The grant was awarded to her for her work on multiple sclerosis and the role of the life extension protein Klotho in the limited repair of white matter in the disease.
Read more »

 

Can Immunization Be a Risk Factor for Multiple Sclerosis?



















A case-control study shows a possible increased risk in the 30 days after vaccination.
Read more »

 

Presidential scholar sets her sights on the underserved



























As a child, Nnenna Ezeh pretended to perform surgery on her dolls. At age 5, she opened up a present on Christmas Day and found a real stethoscope.
Read more »

 

Vitamin B12 Intake Correlated to Physical and Mental Improvements in Multiple Sclerosis Specific Quality of Life: STUDY

Wednesday

 

'Revenge' star Madeleine Stowe speaks out about MS
















































Madeleine Stowe doesn’t have as much in common with her “Revenge” character as you might think.
Read more »

 

Now Aubagio® and Lemtrada® are reimbursed by the RAMQ in Quebec









Mississauga, ON - October 27, 2014 - Genzyme, a Sanofi company, announces that Aubagio® (teriflunomide) and Lemtrada® (alemtuzumab) have be included on the provincial drug formulary under “Médicaments d’exception”.
Read more »

Labels: ,


 

Brainsway (BRSYF.PK) Receives CE Approvals For Treating Multiple Sclerosis (MS), Stroke And Obsessive Compulsive Disorder (OCD)
































Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep Transcranial Magnetic Stimulation) in Europe, for treatment of Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD).
Read more »

 

Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis: STUDY

 

Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis: STUDY

Tuesday

 

OWNER PLEADS FOR HELP: SERVICE DOG MISSING FOR MORE THAN A WEEK























Roberta Valentine has been wheelchair bound with multiple sclerosis for more than 30 years.
Read more »

 

Moscow’s plan to close hospitals and fire doctors threatens social welfare system


























MOSCOW — As the city’s premiere public facility providing palliative care for patients suffering from late-stage cancer, multiple sclerosis and other serious illnesses, Hospital No. 11 is normally a placid place.
Read more »

 

FDA Declines to approve Bristol-Myers hepatitis drug





















Pharmaceutical major Bristol-Myers Squibb, often referred to as BMS has announced on Wednesday that US regulators have declined to approve its experimental treatment for hepatitis C called daclatasvir. It was part of a combination hepatitis C treatment with another antiviral drug called asunaprevir.
Read more »

 

The Charcot Lecture | Beating MS: A story of B cells, with twists and turns: STUDY
















































Jean-Martin Charcot (1825-1893)


Read more »

Labels:


 

The role of cerebellar abnormalities in neuromyelitis optica – a comparison with multiple sclerosis and healthy controls: STUDY


Go to Older News